Detalles de la búsqueda
1.
Assessment of immune functions and MRI disease activity in relapsing-remitting multiple sclerosis patients switching from natalizumab to fingolimod (ToFingo-Successor).
BMC Neurol
; 15: 96, 2015 Jun 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-26099927
2.
Multiple sclerosis endophenotypes identified by high-dimensional blood signatures are associated with distinct disease trajectories.
Sci Transl Med
; 16(740): eade8560, 2024 Mar 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38536936
3.
Immune Cell Profiling During Switching from Natalizumab to Fingolimod Reveals Differential Effects on Systemic Immune-Regulatory Networks and on Trafficking of Non-T Cell Populations into the Cerebrospinal Fluid-Results from the ToFingo Successor Study.
Front Immunol
; 9: 1560, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30050529
Resultados
1 -
3
de 3
1
Próxima >
>>